ARK Related Funds Set To Launch In European Markets

With ARK Invest's ETFs struggling to even match the market, will new European access spell even more doom and gloom for the investment firm?
Dec. 14, 2021
Unlock Free Stock Insights + 50% Off Discount Code!
Join thousands of savvy investors and get:
  • Weekly Stock Picks: Handpicked from 60,000 global options.
  • Ten Must-Have Stocks: Essential picks to hold until 2034.
  • Exclusive Stock Library: In-depth analysis of 60 top stocks.
  • Proven Success: 10-year track record of outperforming the market.
Sign up to our mailing list now and enjoy a 50% discount on premium services!
By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Policy and Terms of Use.

Cathie Wood's ARK Invest firm has experienced widespread investor interest since its inception, with its ETFs some of the most hotly discussed on Wall Street. In a sorry year for ARK, five of its six actively managed funds are currently down year-to-date (YTD). This marks uncharted territory for the company, as it has previously never experienced losses while the wider stock market was seeing gains.

With the company consistently one of the most talked-about investment firms in the world, the news that European investors will now be able to invest in -- or against -- the company will come as little surprise.

How can European investors get involved?

Leverage Shares, a London-based company that offers exchange-traded products (ETPs) to the European market, is offering products that track three of Ark's funds. These are the ARK Innovation ETF (NYSEARCA: ARKK), the ARK Next Generation Internet ETF (NYSEARCA: ARKW), and the ARK Genomic Revolution ETF (BATS: ARKG) respectively.

An ETP is a type of security that tracks underlying securities. In this case, the ETPs available to the European market will directly track Ark's funds to allow the market to gain exposure. Ark's funds aren't registered in the European markets, so investors can utilize these ETP's instead.

Nine total products are to be made available. Three track each ETF with "1:1 exposure," three aim to treble each ETF with long positions, and three actively bet against each ETF with short positions. All nine ETPs went live on the London Stock Exchange today and will be listed on Euronext Amsterdam and Euronext Paris on Thursday. 

Why does this matter to investors?

The wider market will be keen to see how European investors respond to this access. Woods' investing strategy has been brought into question of late, with short interest in many of her company's funds skyrocketing. 

Despite the funds being targeted at long-term investors, current negative returns are certainly likely to have eyebrows raised across Wall Street as investors look to safeguard their money in the midst of a particularly volatile market.


Unlock Free Stock Insights +50% Off Discount Code!
Join thousands of savvy investors and get:
  • Weekly Stock Picks: Handpicked from 60,000 global options.
  • Ten Must-Have Stocks: Essential picks to hold until 2034.
  • Exclusive Stock Library: In-depth analysis of 60 top stocks.
  • Proven Success: 10-year track record of outperforming the market.
Sign up to our mailing list now and enjoy a 50% discount on premium services!
By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Policy and Terms of Use.

The Home of Successful Investing.

© 2024 MyWallSt Ltd. All rights reserved.


Services

Content

Social

Company

Support

Resources


This website is operated by MyWallSt Ltd (“MyWallSt”). MyWallSt is a publisher and a technology platform, not a registered broker-dealer or registered investment adviser, and does not provide investment advice. All information provided by MyWallSt Limited is of a general nature for information and education purposes, and you should not construe any such information as investment advice. MyWallSt Limited does not take your specific needs, investment objectives or financial situation into consideration, and any investments mentioned may not be suitable for you. You should always carry out your own independent verification of facts and data before making any investment decisions, as we cannot guarantee the accuracy or completeness of any information we publish and any opinions that we publish may be wrong and may change at any time without notice. If you are unsure of any investment decision you should seek a professional financial advisor. MyWallSt Limited is not a registered investment adviser and we do not provide regulated investment advice or recommendations. MyWallSt Limited is not regulated by the Central Bank of Ireland. MyWallSt Limited may provide hyperlinks to web sites operated by third parties. Your use of third party web sites and content, including without limitation, your use of any information, data, advertising, products, or other materials on or available through such web sites, is at your own risk and is subject to the third parties' terms of use.